Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2013.
The company has reported 15.71% rise in its net profit at Rs 85.88 crore for the quarter as compared to Rs 74.22 crore for the same quarter in the previous year. However, total income of the company decreased by 16.56% to Rs 759.63 crore for quarter under review as compared to Rs 910.36 crore for the quarter ended December 31, 2012.
On the consolidated basis, the group has reported 73.61% rise in its net profit after taxes and minority interest at Rs 1531.09 crore for the quarter ended December 31, 2013, as compared to Rs 881.30 crore for the same quarter in the previous year. Total income of the group has increased by 51.60% at Rs 4446.82 crore for quarter under review as compared to Rs 2933.33 crore for the quarter ended December 31, 2012.
The company has reported 15.71% rise in its net profit at Rs 85.88 crore for the quarter as compared to Rs 74.22 crore for the same quarter in the previous year. However, total income of the company decreased by 16.56% to Rs 759.63 crore for quarter under review as compared to Rs 910.36 crore for the quarter ended December 31, 2012.
On the consolidated basis, the group has reported 73.61% rise in its net profit after taxes and minority interest at Rs 1531.09 crore for the quarter ended December 31, 2013, as compared to Rs 881.30 crore for the same quarter in the previous year. Total income of the group has increased by 51.60% at Rs 4446.82 crore for quarter under review as compared to Rs 2933.33 crore for the quarter ended December 31, 2012.
No comments:
Post a Comment